This market resolves to “YES” if Apple, Google (Alphabet), Microsoft, or Meta publicly announce the acquisition of a neurotechnology-focused startup by December 31, 2025. The acquisition must be confirmed by an official press release, regulatory filings, or reputable media reports (e.g., Bloomberg, Reuters, TechCrunch).

• A neurotechnology startup is defined as a company primarily working on brain-computer interfaces (BCIs), EEG-based systems, neural implants, neuromodulation, or direct brainwave interaction technologies.

• The startup must have been independent before acquisition (spin-offs or internal divisions do not count).

• The acquiring company must be Apple, Google (Alphabet), Microsoft, or Meta—acquisitions by their subsidiaries (e.g., DeepMind, Oculus) count only if the parent company is explicitly involved.

• Major tech companies are investing in neurotech (e.g., Meta’s CTRL-Labs acquisition, Apple’s health initiatives).

• Startups in BCI, EEG wearables, and neuromodulation are growing rapidly.

• Regulatory and ethical concerns could slow down acquisitions.

Will a major tech company secure a foothold in neurotech through acquisition by 2025, or will they stick to internal R&D?